Wolverine Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Wolverine Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-125,265	Closed	-$1.81M	–	1740
2026 Q1	$1.81M	Buy	125,265 +100,949	+415%	+$1.45M	0.02%	602
2025 Q4	$346K	Buy	+24,316	New	+$239K	﹤0.01%	1009
2020 Q1	–	Sell	-3,951	Closed	-$38K	–	1517
2019 Q4	$38K	Hold	3,951	–	–	﹤0.01%	1195
2019 Q3	$31K	Hold	3,951	–	–	﹤0.01%	1256
2019 Q2	$49K	Buy	+3,951	New	+$50.1K	﹤0.01%	1203
2014 Q1	–	Sell	-37,000	Closed	-$86K	–	2559
2013 Q4	$86K	Buy	+37,000	New	+$81.2K	﹤0.01%	1513

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Wolverine Asset Management's FOLD Position: Q2 2026 in Review

Wolverine Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 125,265 shares — an estimated $1.81M sold.

Wolverine Asset Management first reported a position in FOLD in Q4 2013 and held it in 6 quarters. The position peaked at $1.81M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Wolverine Asset Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Wolverine Asset Management sold 125,265 Amicus Therapeutics shares in Q2 2026, an estimated $1.81M.
Wolverine Asset Management first reported a position in Amicus Therapeutics in Q4 2013 and held it in 6 quarters.
Wolverine Asset Management's Amicus Therapeutics position peaked at $1.81M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.